ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.82
0.00%
US Tech 100
19,054.00
1.01%
S&P 500
5,572.07
-0.76%
US Dollar vs CAD
1.44157
-0.12%
Bitcoin
83,185.77
0.41%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Elevation Oncology Inc (ELEV)

  7. Elevation Oncology Inc (ELEV) News

ELEV

Elevation Oncology (ELEV)

Elevation Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELEV
DateTimeSourceHeadlineSymbolCompany
03/06/20254:12PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELEVElevation Oncology Inc
03/06/20253:52PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
03/06/20253:30PMPR Newswire (US)Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business AchievementsNASDAQ:ELEVElevation Oncology Inc
02/25/20256:30AMPR Newswire (US)Elevation Oncology to Participate in Upcoming Investor ConferencesNASDAQ:ELEVElevation Oncology Inc
02/19/20253:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
02/19/20253:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
02/19/20253:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
02/14/202512:34PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELEVElevation Oncology Inc
01/31/20253:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
01/13/20256:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
01/13/20256:30AMPR Newswire (US)Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming MilestonesNASDAQ:ELEVElevation Oncology Inc
12/12/20246:30AMPR Newswire (US)Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid TumorsNASDAQ:ELEVElevation Oncology Inc
12/05/20246:30AMPR Newswire (US)Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024NASDAQ:ELEVElevation Oncology Inc
11/26/20246:30AMPR Newswire (US)Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:ELEVElevation Oncology Inc
11/19/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
11/14/20246:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELEVElevation Oncology Inc
11/06/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
11/06/20246:30AMPR Newswire (US)Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business AchievementsNASDAQ:ELEVElevation Oncology Inc
11/06/20246:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELEVElevation Oncology Inc
09/23/20246:30AMPR Newswire (US)Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2NASDAQ:ELEVElevation Oncology Inc
09/20/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
09/03/20246:30AMPR Newswire (US)Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ELEVElevation Oncology Inc
08/19/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
08/06/20246:45AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELEVElevation Oncology Inc
08/06/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELEVElevation Oncology Inc
08/06/20246:10AMPR Newswire (US)Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business AchievementsNASDAQ:ELEVElevation Oncology Inc
08/06/20246:00AMPR Newswire (US)Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2NASDAQ:ELEVElevation Oncology Inc
07/15/202412:17PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELEVElevation Oncology Inc
06/27/20246:30AMPR Newswire (US)Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction CancerNASDAQ:ELEVElevation Oncology Inc
06/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELEVElevation Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:ELEV

Your Recent History

NASDAQ
FCEL
FuelCell Energy
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
TGLO
TheGlobe com (PK)
NASDAQ
AMRN
Amarin
USOTC
NBRI
North Bay Resources (PK)
USOTC
RITE
MineralRite (PK)
NASDAQ
NB
NioCorp Developments
USOTC
RNVA
Rennova Health (CE)
USOTC
AZRH
Azure (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
COIN
BTCUSD
Bitcoin
NASDAQ
COOP
Mr Cooper
NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
USOTC
GVSI
Good Vibrations Shoes (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads